GALAPAGOS

galapagos-logo

Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.

#SimilarOrganizations #People #Financial #Event #Website #More

GALAPAGOS

Social Links:

Industry:
Biopharma Biotechnology Clinical Trials Health Care Medical

Founded:
1999-01-01

Address:
Mechelen-bovelingen, Limburg, Belgium

Country:
Belgium

Website Url:
http://www.glpg.com

Total Employee:
251+

Status:
Active

Contact:
+32 15 34 29 00

Email Addresses:
dpo@glpg.com

Total Funding:
5.45 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network


Similar Organizations

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.


Current Advisors List

onno-stolpe_image

Onno Stolpe Member of Board of Directors @ Galapagos
Board_member
1999-01-01

katrine-bosley_image

Katrine Bosley Board Member @ Galapagos
Board_member
2013-01-01

stephen-bunting_image

Stephen Bunting Board memeber @ Galapagos
Board_member

Current Employees Featured

onno-stolpe_image

Onno Stolpe
Onno Stolpe CEO @ Galapagos
CEO
1999-01-01

werner-cautreels_image

Werner Cautreels
Werner Cautreels Director @ Galapagos
Director

andre-hoekema_image

Andre Hoekema
Andre Hoekema Chief Business Officer @ Galapagos
Chief Business Officer

bart-filius_image

Bart Filius
Bart Filius Chief Operating Officer & Chief Financial Officer @ Galapagos
Chief Operating Officer & Chief Financial Officer

walid-abi-saab_image

Walid Abi-Saab
Walid Abi-Saab Chief Medical Officer @ Galapagos
Chief Medical Officer

piet-wigerinck_image

Piet Wigerinck
Piet Wigerinck Chief Scientific Officer @ Galapagos
Chief Scientific Officer

kruti-popat_image

Kruti Popat
Kruti Popat Director, Customer Insights & Engagement @ Galapagos
Director, Customer Insights & Engagement

paul-passier_image

Paul Passier
Paul Passier Director Clinical Pharmacology @ Galapagos
Director Clinical Pharmacology
2018-01-01

michele-manto_image

Michele Manto
Michele Manto Chief Commercial Officer @ Galapagos
Chief Commercial Officer
2020-01-01

philip-vyt_image

Philip Vyt
Philip Vyt Senior Director Global Omnichannel Capabilities & Digital Innovation @ Galapagos
Senior Director Global Omnichannel Capabilities & Digital Innovation
2020-10-01

Founder


dinko-valerio_image

Dinko Valerio

onno-stolpe_image

Onno Stolpe

rudi-pauwels_image

Rudi Pauwels

Stock Details


Company's stock symbol is VIE:GLPG

Acquisitions List

Date Company Article Price
2022-06-21 CellPoint CellPoint acquired by Galapagos 125 M EUR
2021-06-21 Abound Bio Abound Bio acquired by Galapagos 14 M USD
2013-01-15 Cangenix Cangenix acquired by Galapagos N/A
2010-02-02 Argenta Discovery Argenta Discovery acquired by Galapagos N/A
2007-01-02 ProStrakan ProStrakan acquired by Galapagos 31 M EUR
2006-12-07 Inpharmatica Inpharmatica acquired by Galapagos 19.1 M EUR
2005-09-21 BioFocus DPI BioFocus DPI acquired by Galapagos 36.5 M USD

Investors List

gilead-sciences_image

Gilead Sciences

Gilead Sciences investment in Post-IPO Equity - Galapagos

university-of-antwerp_image

University of Antwerp

University of Antwerp investment in Grant - Galapagos

van-herk-ventures_image

Van Herk Ventures

Van Herk Ventures investment in Post-IPO Equity - Galapagos

the-institute-for-the-promotion-of-innovation-by-science-and-technology-in-flanders_image

The Institute for the Promotion of Innovation by Science and Technology in Flanders

The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos

thuja-capital_image

Thuja Capital

Thuja Capital investment in Venture Round - Galapagos

the-institute-for-the-promotion-of-innovation-by-science-and-technology-in-flanders_image

The Institute for the Promotion of Innovation by Science and Technology in Flanders

The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos

the-institute-for-the-promotion-of-innovation-by-science-and-technology-in-flanders_image

The Institute for the Promotion of Innovation by Science and Technology in Flanders

The Institute for the Promotion of Innovation by Science and Technology in Flanders investment in Grant - Galapagos

gilde-healthcare-partners_image

Gilde Healthcare

Gilde Healthcare investment in Venture Round - Galapagos

Investments List

Date Company Article Money raised
2013-07-01 Vitalnext Galapagos investment in Funding Round - Vitalnext N/A

Key Employee Changes

Date New article
2022-01-26 Galapagos appoints Paul Stoffels as Chief Executive Officer

Official Site Inspections

http://www.glpg.com Semrush global rank: 39.37 K Semrush visits lastest month: 3.28 M

  • Host name: s3-website-eu-west-1.amazonaws.com
  • IP address: 52.92.32.4
  • Location: Boardman United States
  • Latitude: 45.8491
  • Longitude: -119.7143
  • Metro Code: 810
  • Timezone: America/Los_Angeles
  • Postal: 97818

Loading ...

More informations about "Galapagos"

Galapagos - Pioneering for patients

Our Intent to Separate into Two Publicly Traded Entities. On January 8, we announced a planned separation into two entities: Galapagos, which would continue to advance its global cell therapy leadership in addressing high …See details»

About Us - Galapagos

About Us. At Galapagos, we are united around a single purpose: to transform patient outcomes through life-changing science and innovation for more years of life and quality of life across the …See details»

Galapagos announces full year 2023 results and outlook for 2024

Dec 31, 2023 Webcast presentation tomorrow, 23 February 2024, at 14:00 CET / 8:00 am ET, www.glpg.com. Mechelen, Belgium; 22 February 2024, 22:01 CET; regulated information – …See details»

GLPG - Crunchbase Company Profile & Funding

GLPG is an investment and development consultancy that offers advisory services. New. Resources. Advanced Search ... Log In. Experience the new …See details»

Organization, structure and operation - Galapagos …

Organization, structure and operation. CSR report. Galapagos NV • Annual Report 2019. Our future success depends on our ability to retain the members of our executive committee and to attract, retain and motivate qualified …See details»

Corporate Governance - Galapagos

Oct 7, 2024 Tax Governance. For more information on our tax governance, please consult the Galapagos Global Tax Strategy.. Statutory Auditor. BDO Bedrijfsrevisoren BV, a limited liability company (besloten vennootschap / …See details»

Our Journey - Our Company - Galapagos NV Annual …

Our Strategy. We are a fully integrated biotechnology company united around a single purpose: to transform patient outcomes worldwide through the relentless pursuit of life changing science and innovation for more years of life and …See details»

GLPG US, Inc. Company Profile | Pittsburgh, PA | Competitors ...

Find company research, competitor information, contact details & financial data for GLPG US, Inc. of Pittsburgh, PA. Get the latest business insights from Dun & Bradstreet.See details»

Galapagos - Crunchbase Company Profile & Funding

Organization. Galapagos . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Galapagos is a clinical-stage biotechnology …See details»

GLPG

GLPG is a trading style of GLPG Limited (company no. 09871398) and GLPG Finance Limited (company no. 12754335), both registered at 66 Prescot Street, London, E1 8NN. We are registered with the ICO, references ZA162816 …See details»

Organization, structure and operation - Galapagos Annual Report …

Organization, structure and operation. CSR report. Galapagos NV • Annual Report 2020. Our future success depends on our ability to retain the members of our management board and to …See details»

Galapagos NV Annual Report 2022

Financial highlights - Group net revenue, Cash position and more. A message from the CEO and Chairman and the entire Annual Report 2022 of Galapagos NV.See details»

Galapagos to Unlock Shareholder Value by Declaring its Intent to ...

Jan 8, 2025 Media inquiries: Srikant Ramaswami +1 412 699 0359 Marieke Vermeersch +32 479 490 603 media@glpg.com Investor inquiries: Srikant Ramaswami +1 412 699 0359 …See details»

Intended Separation - Galapagos - glpg.com

Galapagos Executing a Focused Cell Therapy Vision in Oncology. Galapagos will focus on unlocking the broad potential of its decentralized cell therapy manufacturing platform in …See details»

5 Reasons to Join the GLPG Network

GLPG provides: A steady stream of referrals to help therapists build their practices quickly and maintain their desired caseload. Credentialing experts to make sure each therapist in the …See details»

LNG could help break Canada's dependence on the U.S. energy …

4 days ago His organization published a report in December that noted an overbuild of LNG globally, uncertain demand in emerging markets, high Canadian production costs and political …See details»

Sustainability - Galapagos

Corporate Governance. Our commitment to Corporate Governance. We believe in transparency, accountability, and ethical leadership. To learn more about our corporate governance …See details»

Our Sustainability Governance - Galapagos NV Annual Report 2024

Home; Sustainability Statements; General Disclosures; Our Sustainability Governance; Our Sustainability Governance In 2022, together with the members of our Executive Committee, …See details»

Letter from the CEO and Chairman - Galapagos NV Annual Report …

Home; The Galapagos group; Letter from the CEO and Chairman; Letter from the CEO and Chairman Dr. Paul Stoffels 1. As I reflect on my first year as the CEO and Chairman of the …See details»

Webcasts & Events - Galapagos

Date Event Webcast; February 12, 2025: Full year 2024 results: February 13, 2025: March 27, 2025: Annual report 2024 – April 23, 2025: First quarter 2025 resultsSee details»

linkstock.net © 2022. All rights reserved